Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Behavioral & Substance Use Disorder Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (https://rgd.mcw.edu/rgdweb/contact/contactus.html).
Term:liver tumorous lesion number
go back to main search page
Accession:CMO:0001068 term browser browse the term
Definition:The number of tumorous lesions in or on the surface of the liver, or in a specified section of the liver, the large, highly vascularized organ located in the abdomen of vertebrates that secretes bile and is active in the formation of certain blood proteins, in the metabolism of carbohydrates, fats, and proteins and in the detoxification of noxious substances. A tumorous lesion is one which is or has the potential to become a tumor, that is, a neoplasm or new growth of tissue in which cell multiplication is more or less uncontrolled and progressive. Tumorous lesions include tumors, preneoplastic lesions, and hyperplastic lesions composed of histologically normal cells.
Synonyms:related_synonym: hepatic tumorous lesion number


show annotations for term's descendants           Sort by:
liver tumorous lesion number term browser
Symbol Object Name Evidence rsID P Value LOD Score Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcar10 Hepatocarcinoma resistance QTL 10 IDA 2.9 RGD PMID:12154055 RGD:629566 NCBI chr 8:49,610,204...68,373,388 JBrowse link
Q Hcar11 Hepatocarcinoma resistance QTL 11 IDA 4.4 RGD PMID:12154055 RGD:629566 NCBI chr 6:46,050,607...116,278,722 JBrowse link
Q Hcar15 Hepatocarcinoma resistance QTL 15 IDA 0.05 RGD PMID:15771619 RGD:1358145 NCBI chr 1:162,548,015...270,518,180 JBrowse link
Q Hcar5 Hepatocarcinoma resistance QTL 5 IDA 8.0 RGD PMID:10850431 RGD:619609 NCBI chr 1:223,964,326...236,074,012 JBrowse link
Q Hcar7 Hepatocarcinoma resistance QTL 7 IDA 7.8 RGD PMID:10850431 RGD:619609 NCBI chr 4:61,041,057...94,638,356 JBrowse link
Q Hcas2 Hepatocarcinoma susceptibility QTL 2 IDA 1.0E-4 3.0 RGD PMID:10493520 RGD:619598 NCBI chr 1:7,746,118...52,746,118 JBrowse link
Q Hcas5 Hepatocarcinoma susceptibility QTL 5 IDA 3.12 RGD PMID:15185337 RGD:737884 NCBI chr 1:185,857,683...270,518,180 JBrowse link
Q Hcas8 Hepatocarcinoma susceptibility QTL 8 IDA RGD PMID:17079458 RGD:1599590 NCBI chr16:16,278,184...27,244,292 JBrowse link
liver nonremodeling tumorous lesion number term browser
Symbol Object Name Evidence rsID P Value LOD Score Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcar14 Hepatocarcinoma resistance QTL 14 IDA 4.3 RGD PMID:15185337 RGD:737884 NCBI chr18:57,825,243...85,493,247 JBrowse link
liver remodeling tumorous lesion number term browser
Symbol Object Name Evidence rsID P Value LOD Score Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Lnnr3 Liver neoplastic nodule remodeling QTL 3 IDA 2.94 RGD PMID:15185337 RGD:737884 NCBI chr 2:1...42,977,529 JBrowse link
Q Lnnr4 Liver neoplastic nodule remodeling QTL 4 IDA 3.64 RGD PMID:15185337 RGD:737884 NCBI chr13:1...34,785,618 JBrowse link
Q Lnnr5 Liver neoplastic nodule remodeling QTL 5 IDA 3.29 RGD PMID:15185337 RGD:737884 NCBI chr13:62,424,592...88,113,509 JBrowse link
Q Lnnr6 Liver neoplastic nodule remodeling QTL 6 IDA 3.3 RGD PMID:15185337 RGD:737884 NCBI chr13:65,613,454...109,350,286 JBrowse link
liver remodeling tumorous lesion number to liver total tumorous lesion number ratio term browser
Symbol Object Name Evidence rsID P Value LOD Score Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Lnnr1 Liver neoplastic nodule remodeling QTL 1 IDA 0.001 3.85 RGD PMID:12672032 RGD:629574 NCBI chr 7:36,178,764...81,178,764 JBrowse link
Q Lnnr2 Liver neoplastic nodule remodeling QTL 2 IDA 5.0E-4 2.9 RGD PMID:12672032 RGD:629574 NCBI chr 1:243,953,669...270,518,180 JBrowse link
liver tumorous lesion number to liver area ratio term browser
Symbol Object Name Evidence rsID P Value LOD Score Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcar4 Hepatocarcinoma resistance QTL 4 IDA 4.6 RGD PMID:10850431 RGD:619609 NCBI chr 1:202,851,915...223,964,440 JBrowse link
Term paths to the root
Path 1
Term Annotations click to browse term
  clinical measurement 2369
    organ measurement 485
      organ lesion measurement 140
        organ tumorous lesion measurement 108
          liver tumorous lesion measurement 29
            liver tumorous lesion number 16
              calculated liver tumorous lesion number + 3
              liver nonremodeling tumorous lesion number 1
              liver remodeling tumorous lesion number + 6
              liver tumor number + 0
paths to the root